Cystic Fibrosis Mutation Screening (CFTR – Del 508)
Introduction
Cystic Fibrosis Mutation Screening (CFTR – Del 508) is a vital genetic test that identifies mutations in the CFTR gene, which are responsible for Cystic Fibrosis (CF). This condition affects the lungs and digestive system, leading to severe respiratory and nutritional complications. Early detection through this screening can significantly improve management and treatment options for affected individuals.
What the Test Measures
This test specifically detects the Del 508 mutation in the CFTR gene, which is the most common mutation associated with Cystic Fibrosis. By identifying this mutation, healthcare providers can assess the risk of developing CF and guide appropriate treatment plans.
Who Should Consider This Test
Individuals who should consider Cystic Fibrosis Mutation Screening include:
- Those with a family history of Cystic Fibrosis.
- Individuals experiencing symptoms such as chronic cough, frequent lung infections, or difficulty in gaining weight.
- Couples planning to conceive, especially if one partner is a carrier of the CFTR mutation.
Benefits of Taking the Test
Taking the Cystic Fibrosis Mutation Screening offers several benefits:
- Early diagnosis and management of Cystic Fibrosis.
- Informed family planning options for couples.
- Access to specialized care and treatment plans tailored to individual needs.
Understanding Your Results
Results from the Cystic Fibrosis Mutation Screening will typically be available within 7-8 days. A positive result indicates the presence of the Del 508 mutation, while a negative result suggests that the mutation is not present. However, it is essential to discuss results with a healthcare provider for a comprehensive understanding and next steps.
Test Details and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
Cystic Fibrosis Mutation Screening (CFTR – Del 508) | 12,000 KSh | 16,000 KSh |
Sample Type and Pre-Test Instructions
The sample for this test is collected from peripheral blood using an EDTA Vacutainer (2ml). It is important to note that the Cystic Fibrosis mutation screening requires a doctor’s prescription, which is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Book Your Test Today!
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Take control of your health today by booking the Cystic Fibrosis Mutation Screening (CFTR – Del 508) test. For more information or to schedule your appointment, please call or WhatsApp us at +254711564616.